ロード中...
Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
BACKGROUND: The risk-benefit relationship of memantine treatment for Alzheimer’s disease (AD) remains unclear. In addition, variability between the results of clinical trials has been observed. The aim of this study was to investigate the risk-benefit relationship of memantine treatment in patients...
保存先:
| 出版年: | BMC Geriatr |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6057050/ https://ncbi.nlm.nih.gov/pubmed/30041625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12877-018-0857-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|